Jiping Fu
34Patents
5h-index
46Co-inventors
65Inventor score
Filing activity: Apr 9, 2007 → Jul 12, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9845325B2 | Tetracyclic pyridone compounds as antivirals | Chemistry; Metallurgy | 22 | Active |
| US9549916B2 | Isoxazole hydroxamic acid compounds as LpxC inhibitors | Emerging Cross-Sectional Technologies | 10 | Active |
| US8222425B2 | Organic compounds and their uses | Chemistry; Metallurgy | 9 | Active |
| US8008263B2 | Organic compounds and their uses | Chemistry; Metallurgy | 8 | Active |
| US7825152B2 | Organic compounds and their uses | Human Necessities | 6 | Active |
| US10301312B2 | Fused indazole pyridone compounds as antivirals | Chemistry; Metallurgy | 5 | Active |
| US8211932B2 | Organic compounds and their uses | Human Necessities | 4 | Active |
| US11267782B2 | Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors | Chemistry; Metallurgy | 4 | Active |
| US10894797B2 | Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US8324239B2 | Furopyridine compounds and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US11034705B2 | Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors | Chemistry; Metallurgy | 3 | Active |
| US8445527B2 | Organic compounds and their uses | Human Necessities | 3 | Active |
| US10093673B2 | Tetracyclic pyridone compounds as antivirals | Chemistry; Metallurgy | 3 | Active |
| US11753366B2 | Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors | Chemistry; Metallurgy | 2 | Active |
| US11420936B2 | Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases | Chemistry; Metallurgy | 2 | Active |
| US11634382B2 | Process of preparing 3-fluoro-5(((1R,2aR)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile | Chemistry; Metallurgy | 2 | Active |
| US9718792B2 | Isoxazoline hydroxamic acid derivatives as LpxC inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US11518772B2 | Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11459340B2 | Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9637482B2 | Isoxazoline hydroxamic acid derivatives as LpxC inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US9566312B2 | Cyclic peptides and use as medicines | Chemistry; Metallurgy | 0 | Active |
| US9498483B2 | 2,3,5-trisubstituted thiophene compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11234977B2 | Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals | Chemistry; Metallurgy | 0 | Active |
| US9815804B2 | Isoxazole hydroxamic acid compounds as LpxC inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US12077506B2 | Indane derivatives as hypoxia inducible factor-2(α) inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.